Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) EBT Margin: 2013-2017

Historic EBT Margin for Tvardi Therapeutics (TVRD) over the last 2 years, with Mar 2017 value amounting to -2,440.72%.

  • Tvardi Therapeutics' EBT Margin rose 15237356.00% to -2,440.72% in Q1 2017 from the same period last year, while for Mar 2017 it was -2,011.84%, marking a year-over-year decrease of 119242.00%. This contributed to the annual value of -67,148.84% for FY2016, which is 6648917.00% down from last year.
  • Tvardi Therapeutics' EBT Margin amounted to -2,440.72% in Q1 2017, which was up 85.34% from -16,650.63% recorded in Q2 2016.
  • Tvardi Therapeutics' EBT Margin's 5-year high stood at -204.39% during Q3 2015, with a 5-year trough of -154,814.29% in Q1 2016.
  • In the last 3 years, Tvardi Therapeutics' EBT Margin had a median value of -1,701.34% in 2015 and averaged -29,287.72%.
  • In the last 5 years, Tvardi Therapeutics' EBT Margin tumbled by 15,385,232bps in 2016 and then skyrocketed by 15,237,356bps in 2017.
  • Quarterly analysis of 5 years shows Tvardi Therapeutics' EBT Margin stood at -215.42% in 2013, then tumbled by 25,658bps to -471.99% in 2014, then spiked by 38,024bps to -204.39% in 2015, then slumped by 1,599,629bps to -16,650.63% in 2016, then soared by 15,237,356bps to -2,440.72% in 2017.
  • Its last three reported values are -2,440.72% in Q1 2017, -16,650.63% for Q2 2016, and -154,814.29% during Q1 2016.